Overview · Filed: Aug 2, 2024
UPC_CoA_464/2024
A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER
AppealsMain AppealCourt of AppealAppealCase Closed
This case cites
Authorities cited within the decisions on file for this case.
EPC article · 3
| Target | Legal point | Strength | Excerpt |
|---|---|---|---|
| 33(4) | jurisdiction — same parties concept for consolidated proceedings | Binding | The concept of the "same parties" of Art. 33(4) UPCA must be understood as requiring the parties to be identical. |
| 56 | inventive step — statutory standard | Binding | A European patent is only validly granted for an invention if ... it involves an inventive step ... if, having regard to the state of the art, it is not obvious to a person skilled in the art (Art. 56 EPC). |
| 69(2) | costs — equitable apportionment on partial success | Binding | The Court of Appeal will therefore apportion the costs equitably pursuant to Art. 69(2) UPCA. |
Rules of Procedure · 2
| Target | Legal point | Strength | Excerpt |
|---|---|---|---|
| 49.2 | claim amendment — admissibility in defence to revocation | Binding | Under R. 49.2 RoP, the Defence to revocation may include an application to amend the patent. |
| 50.2 | claim amendment — subsequent request requires court permission | Binding | Pursuant to R. 50.2 in conjunction with R. 30.2 RoP, a subsequent request to amend the patent may only be admitted into the proceedings with the permission of the Court. |
UPC Court of Appeal · 1
| Target | Legal point | Strength | Excerpt |
|---|---|---|---|
| UPC_CoA_523/2024 | jurisdiction — territorial scope of injunction after Romania accession | Distinguished | Edwards' reference to the Court of Appeal's order in the case of Syngenta v Sumi Agro (UPC_CoA_523/2024, order of 3 March 2025) cannot alter that assessment. |
Cited by
Subsequent UPC decisions citing this case.
| Cited in | Date | Legal point | Strength | Excerpt |
|---|---|---|---|---|
| UPC_CFI_337/2025 Munich CD | Dec 1, 2025 | inventive step and sufficiency | Binding | in light of the Court of Appeal's recent decisions dated 25 November 2025, in cases UPC_CoA_464/2024 and related cases (Meril/Edwards), as well as cases UPC_CoA_528 and 529/2024 (Amgen/Sanofi and Regeneron). |